Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, $.001 Par Value
-
Shares outstanding
-
20.7M
-
Number of holders
-
200
-
Total 13F shares, excl. options
-
19.2M
-
Shares change
-
-524K
-
Total reported value, excl. options
-
$845M
-
Value change
-
-$21.1M
-
Put/Call ratio
-
3.09
-
Number of buys
-
94
-
Number of sells
-
-99
-
Price
-
$44.05
Significant Holders of PETMED EXPRESS INC - Common Stock, $.001 Par Value (PETS) as of Q2 2018
251 filings reported holding PETS - PETMED EXPRESS INC - Common Stock, $.001 Par Value as of Q2 2018.
PETMED EXPRESS INC - Common Stock, $.001 Par Value (PETS) has 200 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.2M shares
of 20.7M outstanding shares and own 92.62% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.92M shares), VANGUARD GROUP INC (2.41M shares), RENAISSANCE TECHNOLOGIES LLC (1.65M shares), DIMENSIONAL FUND ADVISORS LP (905K shares), STATE STREET CORP (786K shares), Epoch Investment Partners, Inc. (500K shares), Penserra Capital Management LLC (404K shares), Copeland Capital Management, LLC (388K shares), Oaktop Capital Management II, L.P. (374K shares), and CITADEL ADVISORS LLC (367K shares).
This table shows the top 200 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.